Negative conversion

[키워드] 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Adverse adverse event adverse events analysed Analysis assigned China Controlled trial coronavirus coronavirus disease Coronavirus disease 2019 covid-19 treatment centre diarrhoea dose Efficacy and safety event followed by Government group hospital Hydroxychloroquine hydroxychloroquine group hydroxychloroquine non-recipient hydroxychloroquine non-recipients hydroxychloroquine recipient hydroxychloroquine recipients Intention intention to treat laboratory confirmed covid-19 Loading dose maintenance dose Mild mild to moderate mild to moderate disease moderate moderate disease negative Negative conversion non-recipients objective open open label outcome measure participant Patient patients principle Probability randomisation randomised controlled trial recipients reported respiratory Result safety population Serious Adverse Events setting severe acute respiratory syndrome Coronavirus severe disease significantly higher Standard of care symptom onset Treatment Trial registration virus were recorded
[DOI] 10.1136/bmj.m1849 PMC 바로가기 [Article Type] Research